Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Mycobacterium smegmatis IL-17A and preparation method thereof

A technology of Mycobacterium smegmatis and IL-17A is applied in the field of recombinant Mycobacterium smegmatis and its preparation, and achieves the effect of good application prospect

Active Publication Date: 2014-08-13
SHANGHAI SIXTH PEOPLES HOSPITAL
View PDF2 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the recombinant Mycobacterium smegmatis expressing IL-17A (Interleukin-17A, Interleukin 17A) has not been reported yet.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Mycobacterium smegmatis IL-17A and preparation method thereof
  • Mycobacterium smegmatis IL-17A and preparation method thereof
  • Mycobacterium smegmatis IL-17A and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0027] The present invention provides a Mycobacterium smegmatis strain IL-17A expressing recombinant interleukin-17A, which is different from the existing Mycobacterium smegmatis in that the Escherichia coli-mycobacterium shuttle expression vector expressing the IL-17A gene is in the Expressed in Mycobacterium smegmatis.

[0028] Its preparation method is as follows:

[0029] Step 1: Design amplification primers based on the known IL-17A gene sequence, and introduce them into the upstream and downstream primers respectively Bam HI restriction site and Hin d III restriction site; obtain the IL-17A gene expression fragment by PCR reaction; clone the IL-17A gene expression fragment into a vector (such as Escherichia coli-mycobacterium shuttle expression vector, pMFA41 vector) to obtain a recombinant vector; Wherein, the acquisition and purification of the IL-17A gene sequence can be operated according to the existing technology, and the operating conditions are introduced in t...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention designs a Mycobacterium smegmatis IL-17A, wherein the Escherichia coli-mycobacterium shuttle expression vector expressing IL-17A gene is expressed in Mycobacterium smegmatis IL-17A; General Microbiology Center of Species Preservation Management Committee, the deposit number is CGMCCNO.4446. The Mycobacterium smegmatis IL-17A of the present invention has the dual function of Mycobacterium smegmatis and IL-17A, so that the recombinant Mycobacterium promotes non-specific anti-infection immunity and inhibits airway immune inflammation mediated by allergens The effect of injury is significantly enhanced, especially in the prevention and control of asthmatic airway injury caused by allergic asthma or respiratory infection.

Description

technical field [0001] The invention relates to a Mycobacterium smegmatis (Mycobacterium smegmatis) strain and a preparation method thereof, in particular to a recombinant Mycobacterium smegmatis expressing IL-17A and a preparation method thereof. Background technique [0002] Immune adjuvant, also known as non-specific immune proliferator, is an auxiliary substance that is injected into the body at the same time or in advance with the antigen, which can enhance the body's immune response or change the type of immune response. It can increase the surface area of ​​the antigen and make the antigen easy to be absorbed by macrophages. Phagocytosis, changing the physical properties of antigens, prolonging the action time of antigens, enhancing the role of helper T cells, stimulating the division of sensitized lymphocytes and the production of plasma cells, improving the titration of antibodies in the body's primary and secondary immune responses, and changing the types and types ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N1/21C12N15/09A61K35/74A61P37/02A61P37/08A61P11/06C12R1/34A61K39/39
Inventor 张建华吴良霞郭盛范小勇陈凌郝春莉
Owner SHANGHAI SIXTH PEOPLES HOSPITAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products